Status:

UNKNOWN

Characterization of Novel Lipoprotein Properties Associated With an Increased Risk to Develop Atherosclerosis

Lead Sponsor:

Sheba Medical Center

Conditions:

Atherosclerosis

Eligibility:

All Genders

18+ years

Brief Summary

Objectives of Medical Research: Separation of LDL and HDL from blood samples of patients with high LDL and / or low HDL who have developed atherosclerotic disease with similar patients who have no ev...

Detailed Description

Participants: Participants who are found suitable during their visit to the Lipid Institute Clinic or during hospitalization at the Sheba Medical Center will receive an explanation of the study, will...

Eligibility Criteria

Inclusion

  • Healthy participants with LDL levels less than 130 mg / dl without evidence of atherosclerosis or wall thickening of the carotid artery according to an ultrasound imaging of the carotid artery at the Lipid Institute and unknown for atherosclerosis or cardiovascular disease in the background.
  • Participants with LDL levels above 160 mg / dl, with no evidence of atherosclerosis or wall thickening of the carotid artery according to an ultrasound - IMT of the carotid arteries performed at the Lipid Institute and unknown for atherosclerosis or cardiovascular disease in the background.
  • Participants with LDL levels above 160 mg / dl, where evidence of atherosclerosis or wall thickening of the arteries can be found by ultrasound imaging of the carotid artery that is performed at the Lipid Institute or known for atherosclerosis or cardiovascular disease in the background.

Exclusion

  • Patients with triglyceride values above 300 mg%, HDL lower than 30 mg%, APOB greater than 150 mg% or LPa higher than 70 mg% will not be included in the study

Key Trial Info

Start Date :

April 27 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 27 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04487223

Start Date

April 27 2020

End Date

April 27 2022

Last Update

October 4 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lipid center

Tel Litwinsky, Israel, 5265601

Characterization of Novel Lipoprotein Properties Associated With an Increased Risk to Develop Atherosclerosis | DecenTrialz